Coeliac disease damages the small intestinal mucosa, whilst Crohn's disease affecting the terminal ileum directly impairs the absorption site
The BPC-157 and TB-500 stack is best suited for: Athletes: Managing soft tissue injuries and wanting to accelerate return to training without compromising repair quality Post-surgical patients: Looking to improve tissue recovery quality and reduce scar formation Chronic tendinopathy patients: Who have not responded adequately to physical therapy alone Inflammation-driven conditions: Where systemic inflammatory signaling or gut permeability is part of the clinical picture The protocol is not appropriate for patients with active cancer or cancer history (growth factor upregulation is contraindicated), autoimmune disease where immune modulation carries additional risk, pregnancy or breastfeeding, or those with compromised liver or kidney function
While our KLOW peptide and Bacteriostatic Reconstitution Water (bac) are sterile, this extra step provides an additional layer of assurance against any adventitious contaminants introduced during the reconstitution process itself
Coverage at NY Times, front page today and my input to that piece Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development
Targets NNMT to enhance fat metabolism and reduce fat cell growth
It means clinicians and patients must make decisions under uncertainty
